Suchergebnisse - "Janetka, James W"

PubPharm (9)

1

Novel approaches to glycomimetic design : development of small molecular weight lectin antagonists

enthalten in: Expert opinion on drug discovery | 2021

von Damalanka, V. | Maddirala, A. | Janetka, J.

2

Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2

enthalten in: Future medicinal chemistry | 2019

von Damalanka, V. | Janetka, J.

3

Precision antimicrobial therapeutics : the path of least resistance?

enthalten in: NPJ biofilms and microbiomes | 2018

von Spaulding, C. | Klein, R. | Schreiber, H. | +2

4

Rational design strategies for FimH antagonists : new drugs on the horizon for urinary tract infection and Crohn's disease

enthalten in: Expert opinion on drug discovery | 2017

von Mydock-McGrane, L. | Hannan, T. | Janetka, J.

5

Mannose-derived FimH antagonists : a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease

enthalten in: Expert opinion on therapeutic patents | 2016

von Mydock-McGrane, L. | Cusumano, Z. | Janetka, J.

6

Death by releasing the breaks : CHK1 inhibitors as cancer therapeutics

enthalten in: Trends in molecular medicine | 2011

von Ma, C. | Janetka, J. | Piwnica-Worms, H.

7

Checkpoint kinase inhibitors : a review of the patent literature

enthalten in: Expert opinion on therapeutic patents | 2009

von Janetka, J. | Ashwell, S.

8

Keeping checkpoint kinases in line : new selective inhibitors in clinical trials

enthalten in: Expert opinion on investigational drugs | 2008

von Ashwell, S. | Janetka, J. | Zabludoff, S.

9

Inhibitors of checkpoint kinases : from discovery to the clinic

enthalten in: Current opinion in drug discovery & development | 2007

von Janetka, J. | Ashwell, S. | Zabludoff, S. | +1

1
[1]